Products - Data Briefs - Number 537
US$ 26.97
comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management - Abdul‐Hafez - 2026 - Endocrinology, Diabetes & Metabolism Cardiovascular outcome studies with GLP-1
Description
69% of patients achieved more than 10% weight loss compared to 9% on placebo
A total of 636 patients were randomized into equally sized four study arms
Many Reddit users report GLP-1 side effects such as constipation, diarrhea, fatigue, low appetite, and nausea
This is a common practice when many similar lawsuits are filed, giving both sides the chance to present the science behind their arguments to the judge overseeing these cases
